Hence, since TGF-β signaling can modulate immunosuppressive activities in several innate and adaptive immune cells (Batlle and Massagué, 2019; Derynck et al., 2021), in this section we discuss how different tumor-derived EVs promote immune evasion through TGF-β signaling. The gene discussed is TGFB1; the disease is neoplasm.